Clark W B, Webb E L, Wheeler T T, Fischlschweiger W, Birdsell D C, Mansheim B J
Infect Immun. 1981 Sep;33(3):908-17. doi: 10.1128/iai.33.3.908-917.1981.
We studied the adsorption, morphological, and serological characteristics of selected Actinomyces and related species. Evaluation of uranyl acetate-stained cells by electron microscopy revealed wide variations among strains in the frequency of surface fimbriae. These variations did not always correlate with the percent adsorption to saliva-treated hydroxyapatite of the various Actinomyces strains. However, two strains of Rothia dentocariosa possessing no surface fimbriae and five strains of A. israelii possessing very few surface fimbriae exhibited feeble adsorption to saliva-treated hydroxyapatite. Although the calculated number of adsorption sites on saliva-treated hydroxypatite did not vary widely among the strains tested, significant differences were observed in the affinities calculated for some species or serotypes. The mean affinities for strains of A. viscosus serotype 2 and A. naeslundii serotype 3 were similar, and these strains adsorbed well to saliva-treated hydroxyapatite. The mean adsorption and affinity for the A. naeslundii strain serotype 1 and all strains of A. israelii tested were significantly less than those determined for the A. viscosus serotype 2 or A. naeslundii serotype 3 strains. Adsorption inhibition activity of antiserum to strain T14V, previously shown to be solely related to antibodies in immune serum directed against the VA1 fimbria (fibril) antigen, was removed by preadsorption of the antiserum with most A. viscosus and A. naelundii strains, but not with A. israelii strains. This suggests some cross-reactivity among strains of A. viscosus and A. naeslundii but not A. israelii. Adsorption to saliva-treated hydroxyapatite of all A. viscosus and A. naeslundii strains tested was strongly inhibited by fimbriae isolated from A. viscosus strain T14V. Collectively, these data suggest that the adsorption of certain A. viscosus and A. naeslundii strains is mediated by surface fimbriae, many of which appear serologically cross-reactive with strain T14V fimbriae.
我们研究了所选放线菌及相关菌种的吸附、形态学和血清学特征。通过电子显微镜对醋酸双氧铀染色的细胞进行评估,发现各菌株表面菌毛的频率存在很大差异。这些差异并不总是与各种放线菌菌株对经唾液处理的羟基磷灰石的吸附百分比相关。然而,两株无表面菌毛的龋齿罗氏菌和五株表面菌毛极少的以色列放线菌对经唾液处理的羟基磷灰石的吸附较弱。尽管在所测试的菌株中,经唾液处理的羟基磷灰石上计算出的吸附位点数量差异不大,但在某些菌种或血清型的计算亲和力方面观察到了显著差异。粘性放线菌血清型2和内氏放线菌血清型3菌株的平均亲和力相似,且这些菌株对经唾液处理的羟基磷灰石吸附良好。内氏放线菌血清型1菌株和所有测试的以色列放线菌菌株的平均吸附和亲和力显著低于粘性放线菌血清型2或内氏放线菌血清型3菌株。之前已证明,抗T14V菌株血清的吸附抑制活性仅与免疫血清中针对VA1菌毛(纤丝)抗原的抗体有关,用大多数粘性放线菌和内氏放线菌菌株预吸附该血清可消除这种活性,但用以色列放线菌菌株预吸附则不能。这表明粘性放线菌和内氏放线菌菌株之间存在一些交叉反应,但以色列放线菌菌株之间不存在。从粘性放线菌T14V菌株分离出的菌毛强烈抑制了所有测试的粘性放线菌和内氏放线菌菌株对经唾液处理的羟基磷灰石的吸附。总体而言,这些数据表明某些粘性放线菌和内氏放线菌菌株的吸附是由表面菌毛介导的,其中许多菌毛在血清学上似乎与T14V菌株菌毛有交叉反应。